Belgian medtech Nyxoah secures €37.5 million EIB venture-debt financing to treat obstructive sleep apnea
The European Investment Bank (EIB) is providing venture debt financing to Belgian medical-technology company Nyxoah €37.5 million to develop treatments against obstructive sleep apnea. This transaction aligns with the EIB’s priority objective to boost research and technological innovation, in line with the implementation of EU policies.